James Meadows, MD
Pulmonary Disease · Savannah, GANPI 1831129303
Payments from drug & device makers
Across 122 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$455
- AstraZeneca$283
- United Therapeutics Corporation$136
- Genentech USA, Inc.$129
- Boehringer Ingelheim$126
- Sunovion Pharmaceuticals Inc.$97
- plus $571 from 15 others
What the payments were for
- Food & beverage$1,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 39 | $455 |
| AstraZeneca | 18 | $283 |
| United Therapeutics Corporation | 8 | $136 |
| Genentech USA, Inc. | 7 | $129 |
| Boehringer Ingelheim | 7 | $126 |
| Sunovion Pharmaceuticals Inc. | 9 | $97 |
| Insmed, Inc. | 6 | $75 |
| Mallinckrodt Hospital Products Inc. | 4 | $70 |
| Jazz Pharmaceuticals Inc. | 4 | $68 |
| Mylan Specialty L.p. | 3 | $59 |
| Pulmonx Corporation | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Grifols USA, LLC | 2 | $32 |
| Sanofi | 2 | $27 |
| Merck | 2 | $24 |
| Harmony Biosciences LLC | 2 | $24 |
| Fisher & Paykel Healthcare Inc | 1 | $18 |
| AbbVie | 1 | $16 |
| Bayer | 1 | $12 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
How this compares
$1,796 in reported general payments places this provider in the 25th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Savannah
- Lawrence McDermottSavannah$963K
- Michael MullinsSavannah$132K
- Michael PerkinsSavannah$67K
- Ryan MoodySavannah$50K
- Maria MascoloRincon$2.7M
- Chad MillerAustell$2M
- Amy CaseAustell$1.5M
- Srihari VeeraraghavanAtlanta$1.3M
- Jose MedinaValdosta$1.3M
- Micah FisherAtlanta$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.